oligomannate
Jump to navigation
Jump to search
Indications
- approved in China for treating mild-moderate Alzheimer's disease
Mechanism of action
- chages gut microbiota
- modulates peripheral & central inflammation
More general terms
References
- ↑ George J Seaweed-Based Drug Approved for Alzheimer's in China - Oligomannate appears to affect gut microbiota, peripheral inflammation. MedPage Today, November 4, 2019 https://www.medpagetoday.com/neurology/alzheimersdisease/83117
- ↑ Bloomberg Neews. April 26, 2020 Chinese Alzheimer's Drug Gets U.S. Approval for Stateside Trial. https://www.msn.com/en-us/health/health-news/chinese-alzheimers-drug-gets-us-approval-for-stateside-trial/ar-BB13dbpY